HomeCompareELV vs FISV

ELV vs FISV: Dividend Comparison 2026

ELV yields 2.41% · FISV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELV wins by $6.69M in total portfolio value
10 years
ELV
ELV
● Live price
2.41%
Share price
$284.79
Annual div
$6.85
5Y div CAGR
81.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.71M
Annual income
$5,527,549.53
Full ELV calculator →
FISV
FISV
● Live price
3.67%
Share price
$54.53
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$464.28
Full FISV calculator →

Portfolio growth — ELV vs FISV

📍 ELV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELVFISV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELV + FISV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ELV pays
FISV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELV
Annual income on $10K today (after 15% tax)
$204.45/yr
After 10yr DRIP, annual income (after tax)
$4,698,417.10/yr
FISV
Annual income on $10K today (after 15% tax)
$311.75/yr
After 10yr DRIP, annual income (after tax)
$394.64/yr
At 15% tax rate, ELV beats the other by $4,698,022.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELV + FISV for your $10,000?

ELV: 50%FISV: 50%
100% FISV50/50100% ELV
Portfolio after 10yr
$3.37M
Annual income
$2,764,006.91/yr
Blended yield
82.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FISV right now

ELV
Analyst Ratings
26
Buy
11
Hold
Consensus: Buy
Price Target
$382.64
+34.4% upside vs current
Range: $332.00 — $425.00
Altman Z
2.8
Piotroski
6/9
FISV
Analyst Ratings
36
Buy
24
Hold
Consensus: Buy
Price Target
$104.18
+91.1% upside vs current
Range: $62.00 — $180.00
Altman Z
0.8
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELV buys
0
FISV buys
0
No recent congressional trades found for ELV or FISV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELVFISV
Forward yield2.41%3.67%
Annual dividend / share$6.85$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR81.2%0%
Portfolio after 10y$6.71M$25.4K
Annual income after 10y$5,527,549.53$464.28
Total dividends collected$6.59M$4.2K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyBuy
Analyst price target$382.64$104.18

Year-by-year: ELV vs FISV ($10,000, DRIP)

YearELV PortfolioELV Income/yrFISV PortfolioFISV Income/yrGap
1← crossover$11,136$435.84$11,067$366.77+$69.00ELV
2$12,737$821.90$12,221$379.34+$516.00ELV
3$15,221$1,592.02$13,468$391.49+$1.8KELV
4$19,508$3,221.71$14,814$403.22+$4.7KELV
5$27,866$6,992.55$16,265$414.50+$11.6KELV
6$46,732$16,915.05$17,829$425.34+$28.9KELV
7$98,041$48,037.84$19,513$435.73+$78.5KELV
8$275,572$170,668.09$21,324$445.68+$254.2KELV
9$1,107,233$812,370.71$23,272$455.20+$1.08MELV
10$6,712,288$5,527,549.53$25,366$464.28+$6.69MELV

ELV vs FISV: Complete Analysis 2026

ELVHealthcare

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Full ELV Calculator →

FISVStock

Fiserv, Inc., together with its subsidiaries, provides payment and financial services technology worldwide. The company operates through Acceptance, Fintech, and Payments segments. The Acceptance segment provides point-of-sale merchant acquiring and digital commerce services; mobile payment services; security and fraud protection products; Carat, an omnichannel commerce solution; Clover, a cloud-based point-of-sale and business management platform; and Clover Connect, an independent software vendors platform. This segment distributes through various channels, including direct sales teams, strategic partnerships with agent sales forces, independent software vendors, financial institutions, and other strategic partners. The Fintech segment offers customer deposit and loan accounts, as well as manages an institution's general ledger and central information files. This segment also provides digital banking, financial and risk management, professional services and consulting, item processing and source capture, and other products and services. The Payments segment offers card transactions, such as debit, credit, and prepaid card processing and services; security and fraud protection products; card production; print services; and various network services, as well as non-card digital payment software and services, including bill payment, account-to-account transfers, person-to-person payments, electronic billing, and security and fraud protection products. It serves business, banks, credit unions, other financial institutions, merchants, and corporate clients. Fiserv, Inc. was incorporated in 1984 and is headquartered in Brookfield, Wisconsin.

Full FISV Calculator →
📬

Get this ELV vs FISV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELV vs SCHDELV vs JEPIELV vs OELV vs KOELV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.